背景:当其他药物治疗失败时,暴发性艰难梭菌感染(CDI)的患者需要紧急腹部结肠切除术,然而死亡率仍然很高。粪便微生物群移植是暴发性CDI患者的侵入性较小的替代方法。我们报告了暴发性CDI患者接受腹部结肠切除术的30天并发症,粪便微生物移植(FMT),或FMT,然后进行腹部结肠切除术(FMT-CO)。方法:我们进行了单中心,回顾性回顾2008年至2016年在大型学术医学中心发生CDI的内科和外科合并患者的病例.队列被确定为暴发性CDI患者,仅接受全腹结肠切除术(CO),单独的FMT(FMT),或FMT-CO。我们分析了病人的人口统计,历史,合并症,临床和实验室变量,CDI严重性评分,和30天的死亡率结果。结果:在回顾期间,我们中心确定了5,150例CDI患者;16例患者符合暴发性CDI的标准,并被纳入本研究。CO队列中有四名患者,FMT队列中有8名患者,FMT-CO队列中的4名患者。所有三组的人口统计学和CDI严重程度评分相似,尽管选定的合并症特征在三个队列中存在显着差异。CO患者的30天死亡率,FMT,FMT-CO组为25%,12.5%,25%,分别。结论:对于暴发性CDI患者,FMT是结肠切除术的替代或辅助治疗,与死亡率增加无关。临床实践中FMT方案的实施将取决于合格移植材料的可用性以及可能受益于FMT的患者的成功早期识别。
BACKGROUND: Urgent abdominal colectomy is indicated for patients with fulminant Clostridioides difficile infection (CDI) when other medical therapies fail, yet mortality remains high. Fecal microbiota transplant is a less invasive alternative approach for patients with fulminant CDI. We report the 30-day complications of patients with fulminant CDI who underwent either abdominal colectomy, fecal microbiota transplantation (FMT), or FMT followed by abdominal colectomy (FMT-CO). Methods: We performed a single-center, retrospective
case review of combined medical and surgical patients with CDI at a large academic medical center between 2008 and 2016. Cohorts were identified as patients with fulminant CDI who underwent total abdominal colectomy alone (CO), FMT alone (FMT), or FMT-CO. We analyzed patient demographics, history, comorbidities, clinical and laboratory variables, CDI severity scores, and mortality outcomes at 30 days. Results: We identified 5,150 patients with CDI at our center during the review period; 16 patients met the criteria for fulminant CDI and were included in this study, with four patients in the CO cohort, eight patients in the FMT cohort, and four patients in the FMT-CO cohort. Demographics and CDI severity scores were similar for all three groups, although the selected comorbidity profiles differed significantly among the three cohorts. The 30-day mortality rates for patients in the CO, FMT, and FMT-CO groups were 25%, 12.5%, and 25%, respectively. Conclusions: FMT is an alternative or adjunctive therapy to colectomy for patients with fulminant CDI that is not associated with increased mortality. Implementation of FMT protocols in clinical practice would be dependent on the availability of qualified transplant material and successful early identification of patients likely to benefit from FMT.